liver venous deprivation
Showing 1 - 25 of >10,000
Liver Venous Deprivation Trial in Hefei (PVE, LVD)
Recruiting
- Liver Venous Deprivation
- PVE
- LVD
-
Hefei, Anhui, ChinaAnhui province hospital
Jul 10, 2022
Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)
Not yet recruiting
- Liver Metastases
- +3 more
- PVE
- +2 more
-
Warsaw, Mazowieckie, PolandSecond Department of Clinical Radiology
Sep 17, 2023
Segment IV Hypertrophy After Liver Venous Deprivation
Completed
- Major Hepatectomy
-
Montpellier, FranceUh Montpellier
Apr 29, 2020
Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase
Recruiting
- Liver Transplant
- PVHA or TACE
-
Shanghai, Shanghai, ChinaThe value of tumor feeding vessels deprivation combined with tyr
Nov 26, 2022
Portal Hypertension, Non-Cirrhotic Portal Hypertension, Non-Cirrhotic Portal Fibrosis Trial in Rio de Janeiro (Hepatic vein
Not yet recruiting
- Portal Hypertension
- +9 more
- Hepatic vein pressure gradient measurement
- +2 more
-
Rio de Janeiro, RJ, BrazilHospital Universitário Clementino Fraga Filho / Universidade Fed
Jan 30, 2023
CVP Measurements in Liver Transplantation
Active, not recruiting
- Liver Failure
- Liver Transplant
-
Cleveland, OhioCleveland Clinic Foundation
Jan 9, 2023
nOmogram of Venous thromboEmbolism in Patients After liveR
Completed
- Venous Thromboembolism
- Liver Transplantation
-
Beijing, Beijing, ChinaBeijing Tsinghua Chang Gung Hosipital
Jan 12, 2022
Rectal Cancer Trial in Gothenburg (Abbreviated MRI of the liver/abdomen, Combined single venous and 3 min equilibrium phase CT
Recruiting
- Rectal Cancer
- Abbreviated MRI of the liver/abdomen
- Combined single venous and 3 min equilibrium phase CT of the abdomen/liver
-
Gothenburg, SwedenSahlgrenska University Hospital/Östra
Apr 26, 2022
Liver Cancer, Surgery, Thrombosis, Deep Vein Trial in Finland, Norway (enoxaparin or tinzaparin or dalteparin, No intervention)
Recruiting
- Liver Cancer
- +4 more
- enoxaparin or tinzaparin or dalteparin
- No intervention
-
Helsinki, Finland
- +5 more
Sep 21, 2022
Hepatolenticular Degeneration; Wilson Trial in Bron, Lyon, Barcelona (Low-volume continuous veno-venous haemodialysis)
Recruiting
- Hepatolenticular Degeneration; Wilson
- Low-volume continuous veno-venous haemodialysis
-
Bron, Rhône-Alpes, France
- +3 more
Jun 27, 2023
A Practical Nomogram Based on Systemic Inflammatory Markers for
Completed
- Systemic Inflammatory Markers
- Portal Vein Thrombosis
- clinical laboratory tests, and imaging characteristics
-
Qingdao, Shandong, Chinathe Affiliated Hospital of Qingdao University
Sep 13, 2022
Comorbidities Resolution After MGB Surgery and Change in Body
Not yet recruiting
- Morbid Obesity
- +7 more
- Mini gastric bypass surgery
- (no location specified)
Aug 28, 2023
Deportalization, Venous Deprivation, Venous Congestion
Completed
- Malignant Liver Tumor
-
Montpellier, FranceUhmontpellier
Aug 8, 2019
Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
Recruiting
- Liver Cirrhosis
- +4 more
- Somatostatin and its analogs
- Endoscopic sclerotherapy, endoscopic variceal ligation, endoscopic tissue glue injection
-
Shenyang, Liaoning, ChinaDepartment of Gastroenterology, General Hospital of Shenyang Mil
Mar 17, 2022
Liver Disease Trial in Aurora (HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate), Hepatic
Completed
- Liver Disease
- HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate)
- Hepatic Venous Pressure Gradient (HVPG)
-
Aurora, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 5, 2021
Liver Metastases Trial in Aurora, Providence (anti-CEA CAR-T cells)
Completed
- Liver Metastases
- anti-CEA CAR-T cells
-
Aurora, Colorado
- +1 more
Oct 20, 2021
Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular
Recruiting
- Cirrhosis
- +3 more
- Apixaban 2.5 MG
- +2 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College, Yangzhou University
Apr 30, 2022
Renal Autotransplantation; Case Series
Enrolling by invitation
- Renal Vascular Disease
- +5 more
- Pre-Operative Information
- +3 more
-
Dallas, TexasLiver Institute of Methodist Dallas Medical Center
Dec 20, 2022
Cirrhosis, Hepatic Encephalopathy Trial in Richmond (One meal)
Recruiting
- Cirrhosis
- Hepatic Encephalopathy
- One meal
-
Richmond, VirginiaHunter Holmes McGuire VA Medical Center
May 11, 2022
Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT
Recruiting
- Hepatic Venous Thrombosis
- Atezolizumab
- Surgery
-
Shanghai, Shanghai, ChinaZhongshan hospital, Fudan University
Feb 15, 2022
Based on Spleen Stiffness, Liver Stiffness and Platelets for
Recruiting
- Portal Hypertension
- Hepatic venous pressure gradient
-
Lanzhou, Gansu, China
- +4 more
May 27, 2022
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Portal Hypertension, Chronic Liver Disease, Cirrhosis Trial in Montréal (Transjugular hepatic venous pressure gradient
Recruiting
- Portal Hypertension
- +2 more
- Transjugular hepatic venous pressure gradient measurement with liver biopsy
- Endoscopic ultrasound portal pressure gradient measurement with liver biopsy
-
Montréal, Quebec, CanadaMcGill University Health Centre
Dec 5, 2021
Living Donor Liver Transplantation to Portal Vein Thrombosis
Completed
- Portal Vein Thrombosis
- Liver Transplant; Complications
- living donor liver transplantation
- Thrombectomy or interposition graft
- (no location specified)
Nov 19, 2021
Liver Cancer Trial in Guangzhou (Irreversible electroporation (IRE))
Completed
- Liver Cancer
- Irreversible electroporation (IRE)
-
Guangzhou, Guangdong, ChinaFuda Cancer Hospital
Sep 1, 2021